Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis
Peta Edler, Megha Rajasekhar, David J. Price, Ishag Adam, Ghulam Rahim Awab, Bridget E. Barber, Larissa W. Brasil, Nathália N. Chamma-Siqueira, Cindy S. Chu, Liwang Cui, André Daher, Lilia González-Cerón, Matthew J. Grigg, Harin Karunajeewa, Marcus V. G. Lacerda, Simone Ladeia-Andrade, Toby Leslie, Benedikt Ley, Kartini Lidia, Alejandro Llanos‐Cuentas, Rhea J. Longley, Laurens Manning, Daniel Abebe Mekonnen, Wuelton Marcelo Monteiro, Brioni R. Moore, François Nosten, Ayodhia Pitaloka Pasaribu, Dhélio B. Pereira, Jeanne Rini Poespoprodjo, Sasithon Pukrittayakamee, Komal Raj Rijal, Kavitha Saravu, André M. Siqueira, Inge Sutanto, Walter R J Taylor, Pham Vinh Thanh, Kamala Thriemer, Sir Nicholas White, Asnakew K. Yeshiwondim, Lina M. Zuluaga-Idarraga, Philippe J. Guérin, Julie A. Simpson, Ric N. Price, Robert J. Commons (2025). Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. , 24(1), DOI: https://doi.org/10.1186/s12936-025-05642-w.
